iShares Nasdaq Biotechnology ETF (IBB)

Add to Watchlists
Create an Alert
112.04 +1.82  +1.65% NASDAQ Feb 15, 20:00 Delayed 2m USD
View Full Chart
IBB Price Chart

IBB Performance

  Total Return (Price) Total Return (NAV) Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M 2.56% 2.54% 5.49% 98
3M 7.58% 7.43% 4.27% 18
6M -2.87% -2.73% -0.45% 76
YTD 16.19% 15.69% 12.61% 19
1Y 1.33% 1.28% 7.41% 81
3Y 10.44% 10.45% 15.51% 80
5Y 5.66% 5.63% 9.81% 84
10Y 16.70% 16.68% 16.10% 40
15Y 10.37% 10.39% 10.49% 51
20Y -- -- 10.49% --
As of Feb. 15, 2019. Returns for periods of 1 year and above are annualized.

IBB Asset Allocation

Type % Net % Long % Short
Cash 0.10% 0.10% 0.00%
Stock 99.90% 99.90% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of Feb. 14, 2019

IBB Region Exposure

Americas 96.91%
North America 96.91%
Latin America 0.00%
Greater Europe 2.42%
United Kingdom 0.79%
Europe Developed 1.52%
Europe Emerging 0.00%
Africa/Middle East 0.11%
Greater Asia 0.67%
Japan 0.00%
Australasia 0.00%
Asia Developed 0.16%
Asia Emerging 0.50%
Market Classification
% Developed Markets 99.50%
% Emerging Markets 0.50%
As of Feb. 14, 2019. Region breakdown data is calculated by using the long position holdings of the portfolio.

IBB Stock Sector Exposure

Basic Materials 0.05%
Communication Services 0.00%
Consumer Cyclical 0.00%
Consumer Defensive 0.00%
Energy 0.00%
Financial Services 0.00%
Healthcare 99.95%
Industrials 0.00%
Real Estate 0.00%
Technology 0.00%
Utilities 0.00%
As of Feb. 14, 2019

IBB Stock Market Capitalization

Giant 14.56%
Large 38.73%
Medium 24.14%
Small 18.23%
Micro 4.33%
As of Feb. 14, 2019

IBB Stock Style Exposure

Large Cap Value 15.46%
Large Cap Blend 16.84%
Large Cap Growth 24.28%
Mid Cap Value 2.31%
Mid Cap Blend 2.81%
Mid Cap Growth 18.38%
Small Cap Value 1.68%
Small Cap Blend 5.98%
Small Cap Growth 12.26%
As of Feb. 14, 2019
View More Holdings

IBB Top 10 Holdings

Symbol Name % Weight Price % Chg
CELG Celgene Corp 8.06% 90.69 +0.01%
BIIB Biogen Inc 7.78% 332.87 +2.51%
GILD Gilead Sciences Inc 7.38% 67.59 +1.84%
AMGN Amgen Inc 7.17% 188.34 +0.89%
ILMN Illumina Inc 5.47% 299.82 +2.51%
REGN Regeneron Pharmaceuticals Inc 4.54% 423.97 +2.17%
VRTX Vertex Pharmaceuticals Inc 4.11% 188.07 +1.27%
ALXN Alexion Pharmaceuticals Inc 3.77% 129.42 +2.77%
INCY Incyte Corp 2.38% 84.15 +0.88%
BMRN Biomarin Pharmaceutical Inc 2.23% 93.99 +0.56%
As of Feb. 14, 2019
Advertisement

IBB One Page Reports

IBB Basic Info

Style
Equity Style Mid Cap/Growth
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Prospectus Objective Specialty - Technology
Fund Owner Firm Name iShares
Benchmark Index
NASDAQ Biotechnology TR USD
100.0%

IBB Manager Info

Name Tenure
Alan Mason 2.80 yrs
Amy Whitelaw 0.50 yrs
Diane Hsiung 11.09 yrs
Greg Savage 11.09 yrs
Jennifer Hsui 6.50 yrs
Rachel Aguirre 0.50 yrs

IBB Net Fund Flows

1M -281.41M
3M -434.82M
6M -846.29M
YTD -281.41M
1Y -1.834B
3Y 248.58M
5Y 1.425B
10Y 2.112B
As of Jan. 31, 2019

IBB Risk Info

Beta (5Y) 1.505
Max Drawdown (All) 62.85%
Historical Sharpe (10Y) 0.9131
Historical Sortino (All) 0.5636
30-Day Rolling Volatility 23.62%
Daily Value at Risk (VaR) 1% (All) 4.83%
Monthly Value at Risk (VaR) 1% (All) 19.27%

IBB Fundamentals

Dividend Yield TTM (2-15-19) 0.28%
30-Day SEC Yield (4-30-18) 0.13%
7-Day SEC Yield --
Weighted Average PE Ratio 24.43
Weighted Average Price to Sales Ratio 5.987
Weighted Average Price to Book Ratio 5.085
Weighted Median ROE 1.19%
Weighted Median ROA -5.11%
Forecasted Dividend Yield 0.52%
Forecasted PE Ratio 14.20
Forecasted Price to Sales Ratio 4.117
Forecasted Price to Book Ratio 3.924
Number of Holdings 225
As of Feb. 14, 2019

IBB Growth Estimates

Forecasted 5 Yr Earnings Growth 15.49%
Forecasted Book Value Growth 6.70%
Forecasted Cash Flow Growth 2.09%
Forecasted Earnings Growth -10.62%
Forecasted Revenue Growth 9.62%
As of Feb. 14, 2019

IBB Comparables

Edit

IBB Attributes

Key Dates
Inception Date 2/5/2001
Termination Date
Last Annual Report Date 3/31/2018
Last Prospectus Date 8/1/2018
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Fixed Distribution Fund No
High-Net Worth Individual Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan Yes
Socially Responsible Fund No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No

IBB Excel Add-In Codes

  • Name: =YCI("IBB","name")
  • Broad Asset Class: =YCI("IBB", "broad_asset_class")
  • Broad Category: =YCI("IBB", "broad_category_group")
  • Prospectus Objective: =YCI("IBB", "prospectus_objective")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.